Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Mandibular Neoplasms × Clear all

Phase

Phase NA 5 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 605 Breast Neoplasms 538 Neoplasms 499 Leukemia, Myeloid, Acute 412 Colorectal Neoplasms 381 Multiple Myeloma 370 Melanoma 360 Prostatic Neoplasms 322 Neoplasm Metastasis 312 Pancreatic Neoplasms 311 Lymphoma 290 Recurrence 281 Ovarian Neoplasms 279 Lung Neoplasms 256 Leukemia 252 Lymphoma, Non-Hodgkin 247 Glioblastoma 238 Precursor Cell Lymphoblastic Leukemia-Lymphoma 214 Stomach Neoplasms 211 Leukemia, Lymphocytic, Chronic, B-Cell 200 Carcinoma, Hepatocellular 197 Squamous Cell Carcinoma of Head and Neck 182 Myelodysplastic Syndromes 182 Lymphoma, Large B-Cell, Diffuse 179 Carcinoma, Renal Cell 174 Brain Neoplasms 152 Lymphoma, Follicular 148 Head and Neck Neoplasms 141 Triple Negative Breast Neoplasms 139 Lymphoma, Mantle-Cell 135

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03678467 2022-05-27

EB-CMF

Epibone, Inc.

Phase 1/2 Unknown

Congenital Abnormalities, Mandibular Injuries, Mandibular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡